Glucagon-like peptide-1 receptor agonists regulate blood sugar, appetite and weight. Educational overview.
Extensive clinical evidence for type 2 diabetes and obesity management.
Nausea, vomiting, pancreatitis risk. Prescription only in UK. Always consult a doctor.
NHS available for eligible patients. Private £150–400/month.